Veracyte, Inc.
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Pro…
Biotechnology
US, South San Francisco [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Veracyte, Inc.'s gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2015 | -1.3600 | -1.304 | 38 | 49 | -29 | -94 | -28 | -5 | -29 | -9 | 40 | 33 |
| 2016 | -1.3000 | -1.225 | 49 | 64 | -33 | -88 | -32 | -7 | -33 | -12 | 47 | 43 |
| 2017 | -1.0900 | -0.866 | 65 | 71 | -31 | -31 | -27 | -23 | -28 | -26 | 52 | 63 |
| 2018 | -0.9100 | -0.703 | 71 | 90 | -31 | -26 | -22 | -19 | -26 | -25 | 55 | 77 |
| 2019 | -0.6200 | -0.200 | 92 | 120 | -22 | -12 | -17 | -6 | -22 | -15 | 65 | 99 |
| 2020 | -0.3600 | -0.614 | 120 | 115 | -16 | -27 | -7 | -19 | -15 | -33 | 82 | 95 |
| 2021 | -0.6700 | -1.137 | 117 | 214 | -35 | -170 | -26 | -156 | -35 | -183 | 89 | 144 |
| 2022 | -1.1100 | -0.608 | 219 | 291 | -75 | -59 | -62 | -40 | -81 | -62 | 181 | 206 |
| 2023 | -0.5100 | -0.712 | 296 | 354 | -36 | -54 | -15 | -44 | -41 | -69 | 174 | 227 |